You are viewing the site in preview mode
Skip to main content
| |
Treatment groups
| |
|---|
|
Demographic Characteristics
|
AM-group (n = 336)
|
PM-group (n = 327)
|
p-value
|
|---|
|
Age (years)
| | | |
|
Mean (SD)
|
35.4 (11.0)
|
36.5 (12.0)
|
0.232a
|
|
Min-Max
|
18–69
|
18–75
| |
|
Age Group (years)
| | | |
|
18–29
|
115 (34.2 %)
|
113 (34.6 %)
| |
|
30–39
|
113 (33.6 %)
|
95 (29.1 %)
| |
|
40–49
|
70 (20.8 %)
|
66 (20.2 %)
| |
|
≥ 50
|
38 (11.3 %)
|
53 (16.2 %)
| |
|
Sex
| | | |
|
Male (%)
|
152 (45)
|
163 (50)
|
0.235b
|
|
Female (%)
|
184 (55)
|
164 (50)
| |
|
Duration of SAR History (years)
| | | |
|
Mean (SD)
|
14.2 (9.2)
|
14.4 (10.3)
|
0.662a
|
|
Min-Max
|
2–50
|
1–55c
| |
- a t-test for differences between the means of the two treatment groups
- b χ2-test for the distribution between the two groups
- c One patient in the PM-group had only one year duration of SAR history although the inclusion criterion was 2 years
